Plx pharma inc. (PLXP)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
REVENUES:
Total revenues

2

-

-

-

317

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Federal grants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

20

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

-

-

41

182

-

-

216

167

81

340

62

375

0

0

0

20

0

-

-

-

-

-

0

-

-

-

-

-

-

OPERATING EXPENSES:
Research and development

513

935

1,214

1,598

992

890

1,219

734

1,079

2,444

958

626

128

-

12

13

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and Development Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,583

3,829

3,457

2,290

1,709

1,959

2,529

2,592

1,816

936

636

33

122

General and administrative

2,493

2,845

2,503

2,433

2,244

1,920

1,800

1,830

2,240

1,911

3,021

4,024

1,217

12

1,041

1,450

2,247

1,684

1,571

1,744

2,478

1,315

1,314

1,327

727

1,316

354

329

283

TOTAL OPERATING EXPENSES

3,007

3,781

3,717

4,032

3,236

2,811

3,019

2,564

3,319

6,650

3,979

4,650

1,345

-3,517

1,053

1,463

5,830

5,513

5,028

4,034

4,187

3,274

3,843

3,920

2,543

2,252

990

363

406

OPERATING LOSS

-3,004

-3,757

-3,676

-3,849

-2,919

-2,523

-2,802

-2,397

-3,237

-6,310

-3,917

-4,275

-1,345

3,517

-1,053

-1,443

-5,830

-5,513

-5,028

-4,034

-4,187

-3,274

-3,843

-3,920

-2,543

-2,252

-990

-363

-406

OTHER INCOME (EXPENSE):
Interest Income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14

9

9

2

0

-

-

-

-

-

-

-

-

Interest income

47

76

111

135

82

78

77

75

66

64

33

14

0

-

0

0

-

-

-

-

-

-

0

0

-

-

-

-

-

Interest and other expense

145

189

230

280

294

296

290

283

275

273

168

642

81

-

28

24

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-4,599

-1,871

-5,498

5,352

7,726

-5,687

408

997

-8,424

1,365

-252

-1,746

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL OTHER INCOME (EXPENSE)

4,500

1,757

5,379

-5,498

-7,939

5,469

-622

-1,206

8,216

-1,574

117

1,118

-81

-

-28

-24

-

-

-

-

-

-

-

-

-

-

-

-

-

INCOME (LOSS) BEFORE INCOME TAXES

1,496

-2,000

1,703

-9,347

-10,858

2,946

-3,425

-3,603

4,978

-7,884

-3,799

-3,156

-1,426

-

-1,082

-1,468

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes

-

-

-

-

-

-

-

-

-

0

0

-920

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCOME (LOSS)

1,496

-2,000

1,703

-9,347

-10,858

2,946

-3,425

-3,603

4,978

-7,884

-3,799

-2,236

-1,426

3,461

-1,082

-1,468

-5,816

-5,504

-5,019

-4,031

-4,187

-3,273

-3,843

-3,920

-2,543

-2,252

-990

-363

-406

Preferred dividends and beneficial conversion feature

320

317

311

301

12,820

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS

1,175

-

1,392

-

-23,679

-

-3,425

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS

-

-

-

-9,649

-

-

-

-3,603

4,978

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) per common share - basic (in dollars per share)

0.08

-0.12

0.09

-1.10

-2.71

0.33

-0.39

-0.41

0.57

-1.06

-0.44

-0.36

-0.33

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) per common share - diluted (in dollars per share)

0.08

-0.12

0.09

-1.10

-2.71

0.33

-0.39

-0.41

0.57

-1.06

-0.44

-0.36

-0.33

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares of common shares - basic (in shares)

9,156

9,212

8,921

8,779

8,750

8,742

8,735

8,729

8,725

8,835

8,704

6,157

4,383

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares of common shares - diluted (in shares)

9,216

9,198

8,936

8,779

8,750

8,742

8,735

8,729

8,725

8,835

8,704

6,157

4,383

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per common share - basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

0.02

-0.25

-0.33

-0.56

-0.54

-0.49

-0.47

-0.49

-0.38

-0.45

-0.46

-0.44

-0.67

-0.21

-0.08

0.09

Weighted average common shares outstanding - basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,548

4,383

4,383

10,315

10,319

10,274

8,584

8,552

8,576

8,537

8,537

5,749

4,922

4,771

4,429

4,370

Grant [Member]
Total revenues

2

-

-

-

317

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

-

-

41

182

-

-

216

167

81

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-